Following our deep dive on lipid nanoparticle (LNP) delivery, Justine Levin-Allerhand sits down with Head of Platform at Mirai Bio, Jagesh Shah for the story behind the data — from why delivery has remained such a persistent challenge to how machine learning, in vivo discovery, and modular LNP design are helping make more precise genetic medicines possible.
Fler avsnitt av The Labs Report
Visa alla avsnitt av The Labs ReportThe Labs Report med Flagship Labs finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
